Endo, M., Machida, R., Tsuchihashi, K., Takahashi, M., Tsukushi, S., Kobayashi, E., Gokita, T., Nakatani, F., Nezu, Y., Tanaka, T., Nakano, K., Hiraga, H., Kataoka, T., Sekino, Y., Sekita, T., Fukuda, H., Oda, Y., Ozaki, T., Tanaka, K. (2026). Final results of a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin, and pazopanib: 2ND-STEP study, JCOG1802.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.11508